chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After second vaccine, had a dry, tracheal cough.; "I" also had a fever; "I" also had a fever, chills, and sore arm, all of which were expected.; "I" also had a fever, chills, and sore arm, all of which were expected.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 21Apr2021 at 14:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The medical history included allergies to shellfish, poison ivy and soap. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were reported as none. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 31Mar2021 at 16:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, after second vaccine, the patient had a dry, tracheal cough. She also had a fever, chills and sore arm, all of which were expected. The cough was not expected and she could find nobody else with that symptom. The cough was the last to resolve. It was substantially better after day 3. The patient reported that she was completely socially isolated prior to the vaccine, so it could not have been caused from another virus. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dry, tracheal cough, fever, chills and sore arm  were recovered on unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Pt received the 2nd dose of the Shingrix vaccine in our office on 1/21/19. After the injection the area was sore, but over the next 2 weeks the pain spread from her deltoid to the surrounding muscles and shoulder joints and progressively got worse. One month later she started to get pain in her L thorax that felt like shingles pain (no vesicles) that lasted for approximately 2 weeks. The pain in her left arm and shoulder still persist. She has throbbing at the injection site that spreads throughout her arm in waves. She has extreme pain when she reaches for anything or elevates her arm that significantly impairs her quality of life. She took some Aleve sparingly which helped and is currently using topical Voltaren gel which provides relief in addition to heat, stretching and massage, but can tell when the medication wears off. She has not felt like the pain has improved as of yet. She denied any redness or swelling and no f/c with the injection. When she received the first injection in 10/2018 she had pain at injection site for 1 month then it resolved.
7AUG97 lt arm red, hot, swollen & tender;had fever, hot to touch since 4AUG97;gave Ibuprofen;seen @ clinic 7AUg97;no fever today;lt arm felt better p/warm compress;
(2/8/15)-rectal temp-103 degrees went up to 104.5. Went to urgent care. Threw up 3xs in waiting room. Nurse checked his urine. Found no UTI. Went home. (2/9/15)-Nurse called but ended up going back b/c he was rolling around on the ground like he was in pain. (2/10/15)-Back to emergency room. (2/11/15)-Ultrasound emergency room. Found nothing. Had rash on body and 1 sore in mouth. Gave him a measles test but it came back negative, was told it was roseola.
Swollen deltoid with pain radiating up into shoulder for 7 days. Attempting to reach parent to  schedule appt
For unknown reason (not documented in chart) patient received the first Moderna COVID-19 Vaccine dose on 08/18/21, the  second dose of Moderna COVID-19 Vaccine on 09/15/21 and a full third dose (not a booster) on 12/15/2021 which is earlier than the required 5 months and outside of the 4-day grace period.  The patient had a hx of lymphoma but has bee in remission for >15 years and does not fall under the moderate immunocompromised category to qualify for a third full dose either. There were no adverse events associated with administration of the vaccine. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
shoulder discomfort starting 2 days p/vax & reported about 1mo later;
Initial misuse report received from a healthcare professional on 05 March 2014. A patient had received a dose of YF Vax on an unspecified date. It was reported that the patient was given just the diluent. No adverse event was reported. List of documents held by sender: none.
No additional adverse events reported; administration of expired ROTATEQ; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.     On 28-JUN-2021, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # 1684154 has been verified to be a valid lot number, expiration date was reported as 24-JUN-2021; strength and route were not reported) 2 ml for prophylaxis. No additional adverse events or product quality complaints were reported.
Moderna COVID-19 Vaccine EUA  received on 3/17 2 minutes from receiving the shot I got slightly dizzy. This did not last long, maybe 20 minutes. By 8 pm that night I was extremely tired and my arm where shot was given was starting to swell a little.  3/18/21 - 6 am I woke up and could not swallow. My throat felt like it does when you have strep. This is still affecting the right side of my throat today two days later 3/19/21. There was also tremendous pressure on my ears like they were going to pop. Again still effecting my right side today two days later.  I ran a fever all the next day between 100 and 101 degrees for most of the following day 3/18.  I had chills which lasted until 9 pm on 3/18. My arm could not be touched where the injection site was. It had swollen and was hard. Today 3/19 it is still very tender but swelling has went down.  I did not go to the doctor as I knew what caused all the issues. I only treated the pain with Tylenol and slept most of the day due to the fatigue.
1st dose - feverish, all over body ache, HA, run down/ tired/ fatigue. 2nd dose - body ache and HA (both not as severe as 1st dose), two days post injection = painful and swollen right axilla lymphadenopathy and right breast pain...used right deltoid for injection  site.  Also, noted fatigue and chills w/o known fever.
Onset of seizure disorder (multiple grand mal and tonic-clonic seizures with associated apnea and cyanosis 10 days after 1st flu and H1N1 shots 1 week after 2nd flu shots had further seizure.
Dad reported swelling. Warmth and redness to left deltoid 1 day after immunization. Area of swelling 7x7 cm. Given BENADRYL and are iced. Resolved on 9/10/16.
shortness of breath and cant do to much movement, Dr prescribed her a pump. Have slight headaches
pt c/o nausea then fainted, 15-30 second loss of consciousness; pt pale, bp 107/46, original, bp 130/53 prior to vax;pt given NS 0.9% IV; pt anxious & not eaten for 6hr consistent w/vasovagal rxn;to ER & discharged @ 230PM;
Patient diagnosed with chickenpox on 8/12/05 after receiving VARIVAX vaccine on 2/19/98.  Still displaying symptoms as of 8/15/05.
10/6 received pneumonia & flu in same arm due to surgery in (L) arm. Received approx 2 p.m. Arm became painful pm of 10/6, 10/7 am arm became swollen & painful.
Light headedness; dizziness; Fast heart rate; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headedness; dizziness), PALPITATIONS (Fast heart rate) and ASTHENIA (Weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension, Migraine and Headache. Concomitant products included NORTRIPTYLINE for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headedness; dizziness), PALPITATIONS (Fast heart rate) and ASTHENIA (Weakness). At the time of the report, DIZZINESS (Light headedness; dizziness), PALPITATIONS (Fast heart rate) and ASTHENIA (Weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 165/101 (Inconclusive) 165/101. On an unknown date, Heart rate: fast (High) fast.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.
pt recv vax & w/in 2 mins pt fell backwards & exp loss of consciousness, striking head on the wall; pt was noted to be pale w/shallow breathing; when pt rested in coma position on the found had an episode of sz activity;dx hypoxia
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On 29-OCT-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # L005563, expiration date 03-NOV-2016 (strength, dose and route of administration were not provided). On 29-OCT-2015 (reported as "a couple hours after administration"), the patient developed severe pain at the injection site and on 30-OCT-2015 (reported as "a couple hours after administration"), the patient developed severe pain at the injection site and on 30-OCT-2015 (reported as "the next day"), the injection site was swollen and very painful. On 31-OCT-2015, the patient went to an unspecified urgent care facility for treatment and was given an unspecified antibiotic. The patient sought medical attention via visiting the urgent care facility. The outcome of the events (the patient's present status) was unknown. The relatedness between the events and PNEUMOVAX 23 was not reported. This is one of two reports received from the same source. Additional information has been requested.
Within 12 hours of second dose of vaccine participant woke up with shooting in hip, had a fever of 101, uncontrollable shaking, feeling of cold and hot. Participant had sweats and headache that lasted 5 day's and lymph node swelling in armpit. Symptoms resolved after about 12 day's.
p/school on 4APR95 pt was flushed, fever 102.7; mom gave APAP q 4 hrs; temp @ MN same day was 103.5 orally; 5APR95 mom of pt took to PMD; MD felt it was a rxn to MMR; pt exp coughing, vomiting;
Symptoms manifested approximately 9 hours after vaccination. Symptoms included fever, extremely severe chills and muscle ache over entire body. The symptoms lasted approximately 24 hours.
This is a spontaneous report from a contactable consumer. A 65-year-old female patient received PREVNAR 13 (lot number and expiry date were not reported), intramuscular on 17Oct2018 at a single dose for pneumonia shot in the physician's office. The patient had no relevant medical history. Ongoing concomitant medications included esomeprazole magnesium (NEXIUM), famotidine (PEPCID), atorvastatin calcium (CARDIOZEN), atorvastatin calcium (LIPITOR), sucralfate (CARAFATE), acetylsalicylic acid (ASPIRIN) 81 mg, lorazepam (ATIVAN), thiamine (VITAMIN B1), colecalciferol (VITAMIN D3), folic acid (FOLIC ACID), and ergocalciferol (VITAMIN D). The patient experienced injection site was red and swollen and it was more like warm to the touch (vaccination site erythema) (non-serious) on 18Oct2018. The outcome of  the events was not recovered. The information on the batch/lot number and expiration date has been requested.
Information has been received from a Nurse Practitioner via field employee referring to a 16 year old male patient. Information regarding medical history and concurrent condition was not reported. On 26-SEP-2014 the patient was vaccinated with the first dose of GARDASIL (lot # K006191, expiration date, dose and route unknown) and the second dose of VAQTA (lot number K004856, expiration date 07-DEC-2016, dose and route unknown). There were no concomitant medications. In the evening of 26-SEP-2014, after leaving the office of the healthcare professional, the patient saw "a racoon carrying a rabbit like it was right in front of him". The patient also had "issues" since an unspecified date after the reported event. Nurse practitioner stated she did not plan on the administration of any additional doses of GARDASIL to this patient. The patient sought medical attention at the office of the nurse practitioner on 02-APR-2015 for an annual visit. The outcome and causality of the events were unknown. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA  Patient experienced severe chills the night of 1/17/2021 with a peak fever of 101.7*F the morning of 1/18/2021.. Patient also experienced fatigue and slept about 12 hours that Sunday and Monday. Non-pharmaceutical treatment consisted of plenty of fluids and bedrest. Pharmaceutical treatment consisted of the use of extended-release acetaminophen. The dose taken was 1300 mg every 8 hours which really helped  with the chills. This was the maximum dose per product label as to ensure a daily intake of less than 4 grams of acetaminophen.
adverse event- fever of 101, pain and soreness on right arm radiating to right side of neck and right ear, severe achiness, ha and intermittent dizziness. treatment- alternate between Tylenol and Aleve. use cold compress as needed. to call if sx persist.
Patient received Pfizer bivalent 12+ dose when Pfizer bivalent 5-11yo dose was indicated.
Red itchy rash around injection site and over the upper arm.  It lasted 4 days and was extremely itchy.  I treated it with Mometasone Furoate Cream USP, 0.1% and Benedryl.  Both were applied twice a day.
After the second shot and after the booster shot I experienced longer and heavier than usual periods. Without prior history of ovarian cysts, on June 1st I ended up in the ER with a burst endometrioma requiring laparoscopic surgery. In September I was again diagnosed with a second ovarian cyst that required surgical removal on October 27th. After getting the booster shot in December, I once again experienced longer/ heavier period and on January 21st another endometrioma burst, which once again required laparoscopic surgery. I?m not sure if there is or isn?t an association between the Covid vaccines and ovarian cysts but thought the progression of events rather coincidental.
19yo Male client had a seizure witnessed by observation nurse after receiving Janssen vaccine. Seizure lasted 4-5 seconds. Client alert and oriented post seizure and reported dizziness. BP 90/64 then 110/78 Client reported not eating for over 24hrs No EMS called Client ambulatory with family upon leave
First GARDASIL injection given on 7/1/13, on 7/8/13 patient called to report that on 7/4 the injection site was swollen and itchy, on 7/6 she started to have hives and was dyspneic. Did not go to ER, took BENADRYL with relief of hives and dyspnea. At this time she is c/o being congested, hives disappearing and no dyspnea.
Pain in armpit area began 6 days after vaccine. Worsened pain on day 7. Cannot palpate a specific swollen lymph node, slight general swelling in the area.
Stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 78-year-old female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; tofacitinib citrate (XELJANZ), at 5 mg 2x/day (5 mg, 2x/day (twice daily)). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid vaccine (dose 1 and 2; manufacturer unknown), for COVID-19 immunisation, reaction(s): "COVID". The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "recovering", described as "Stroke".  Clinical course: The patient had COVID and she took the tofacitinib citrate and then she had a stroke. She is fine now. Just her deformity is off. She stated she has to say 2-3 names before she gets the right one. They took her off tofacitinib citrate for the time being. There is no proof that the tofacitinib citrate caused the stroke, but she did have two COVID vaccines and a booster shot. She got the sroke right after the booster dose. She didn't specify which COVID vaccine she received. They didn't know what caused it because her blood work was fine and the tofacitinib citrate was working great for her. The action taken for tofacitinib citrate was temporarily withdrawn.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a RN concerning a young child who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt developed zoster. Unspecified medical attention was sought.  Additional information has been requested.
injection site pain and swelling; extreme fatigue and tiredness; mild fever (101.1); joint pain; headache; and basically feels like a severe case of the flu on the first and second day but improving some on the second day.
Wednesday, 1/13 @ 2:30 AM: Queasy - took 2 Tums; 2hrs / Body Aches - took 400mg ibuprofen  Thursday 1/14 AM: fatigue, chills, body aches, fever (100.5 degrees), loss of appetite - 800mg ibuprofen initially, 400mg ibuprofen every 6 hours throughout the day, 2.5 hr nap
Information has been received from a nurse concerning her 17 year old daughter who in 2007 received the first and on an unspecified date a second dose of GARDASIL. On 14-AUG-2007 was vaccinated with the third dose of GARDASIL (lot # 655618/0186U) 0.5 ml, IM. On 07-JUL-2008, the patient experienced pain, weakness and numbness in her right thumb and arm. Medical attention was sought, she had blood tests, was seen by a neurologist and will have an Magnetic Resonance Imaging (MRI) the week of 21-JUL-2008. The primary care doctor thought this may be associated with GARDASIL until he saw on the chart that the third dose was given in the opposite arm. At the time of reporting, the patient's pain and weakness and numbness persisted. No additional information at this time. Additional information has been requested.  9/16/2008 MR received from PCP. Seen 7/9/2008 with c/o acute onset of numbness which began in the R thumb and spread up to the level of mid triceps. PE (+) for decreased strength of the fingers, wrist and elbow. Sensory deficit to R mid tricep. Tearful and anxious re: symptoms. Ascending sensory deficit on R hand to upper arm with motor weakness.  Reflexes intact.  Referred to neuro. Neuro consult 7/11/08-improving numbness of unknown etiology. Numbness improving, now only to elbow. Pinprick and touch sensation diminished on R arm. F/U visit 3 weeks later with continued improvement. Still some numbness and decreased sensation of the hand. Will f/u with EMG and/or MRI PRN.
Patient suffered an exacerbation of her Parkinson's after receiving this season's Fluzone Quadrivalent; Initial information was received on 05-Dec-2019 regarding an unsolicited valid serious case from a pharmacist.  This case involves female patient (age unknown) who experienced exacerbation of Parkinson's (parkinsonism), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Medical history included Parkinson's disease. The patient's past vaccination included FLUZONE QUADRIVALENT.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot number lot number and other dosing details were not reported] via unknown route in unknown administration site.  On an unknown date, the patient experienced exacerbation of Parkinson's (parkinsonism), (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant.  Details of laboratory data not reported.  Final diagnosis was exacerbation of Parkinson's.   It was not reported if the patient received a corrective treatment.  The patient outcome was unknown for exacerbation of Parkinson's.  Information on the batch number was requested.
Client received Moderna vaccine at 1817 and at 1825 client  intentionally laid down and reported feeling lightheaded, dizzy, and nauseous after receiving injection. Client's skin color appeared pale. Client reports that "this happens every time" she gets vaccines. Client's vital signs were stable: BP 108/72, P 66, O2 99% on room air, and R 16.  Client was assisted to sitting position and given some water. After waiting an additional 15 minutes, client reported that her nausea and dizziness had resolved. Client's color improved.
No additional adverse events reported; Nurse reports the dose of VARIVAX expired on 07/22/2021; This spontaneous report as received from a registered nurse refers to a 38 years old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were not reported.   On 26-JUL-2021, the patient was vaccinated with a dose of expired varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S022757, expiration date 22-JUL-2021, 0.5 milliliter) for prophylaxis (expired product administered). The expiration date was found supported by memo with no temperature excursion. No additional information given. No additional adverse events reported.
Wheal at injection site, localized swelling, joint aches, nausea and vomiting.
Felt lethargic; Couldn't keep any food down; Felt tired; Felt achy; Nauseous; Felt tired - sleeping a lot; Felt very dizzy - everything was spinning; Very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt very dizzy - everything was spinning), HEADACHE (Very bad headache), LETHARGY (Felt lethargic), ABDOMINAL DISCOMFORT (Couldn't keep any food down) and FATIGUE (Felt tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Apr-2021, the patient experienced DIZZINESS (Felt very dizzy - everything was spinning) and HEADACHE (Very bad headache). On an unknown date, the patient experienced LETHARGY (Felt lethargic), ABDOMINAL DISCOMFORT (Couldn't keep any food down), FATIGUE (Felt tired), MYALGIA (Felt achy), NAUSEA (Nauseous) and SOMNOLENCE (Felt tired - sleeping a lot). At the time of the report, DIZZINESS (Felt very dizzy - everything was spinning), HEADACHE (Very bad headache), LETHARGY (Felt lethargic), ABDOMINAL DISCOMFORT (Couldn't keep any food down), FATIGUE (Felt tired), MYALGIA (Felt achy), NAUSEA (Nauseous) and SOMNOLENCE (Felt tired - sleeping a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
100 to 101.3  temperature for more than 24 hours, body aches and severe headache.  rotated Ibuprofen and acetaminophen.
Robust local reaction to Tdap vaccine with reactive axillary adenopathy. Rest, MOTRIN, warm compresses to axilla & injection site.